封面
市場調查報告書
商品編碼
1935233

疫苗細胞培養基市場按培養基類型、應用和地區分類

Cell Culture Media for Vaccine Market, By Media Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

疫苗細胞培養基市場預計到 2026 年將價值 22.176 億美元,預計到 2033 年將達到 37.274 億美元,2026 年至 2033 年的年複合成長率(CAGR)為 7.7%。

報告內容 報告詳情
基準年: 2025 2026年市場規模: 22.176億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
預測期(2026-2033年)複合年成長率: 7.70% 2033 年的預測值: 37.274億美元

細胞培養基包含適當的能源來源以及支持細胞生長和調節細胞週期的化合物。典型的細胞培養基包含維生素、無機鹽、胺基酸補充劑、葡萄糖和血清,血清作為生長因子、荷爾蒙和黏附因子的來源。此外,培養基也有助於維持pH值和滲透壓。

市場動態

感染疾病的上升趨勢是推動全球疫苗細胞培養基市場成長的主要因素。根據美國疾病管制與預防中心(CDC)統計,2017年8月美國報告了約104例經檢查室確診的流感相關兒童死亡病例,其中66例與甲型流感病毒相關,38例與乙型流感病毒相關。此外,政府為意識提升而採取的措施預計也將推動市場成長。例如,根據美國疾病管制與預防中心(CDC)統計,2015年流感疫苗接種預防了約190萬例流感病例、96.6萬例流感相關就診和約6.7萬例流感相關住院,使美國的疾病負擔降低了6.5%。

然而,污染風險較高可能會阻礙市場成長:根據 ResearchGate 2014 年的一篇報導,已知牛(FBS) 含有內毒素、黴漿菌、病毒污染物和朊病毒等因素,這些因素會導致牛腦病變(BSE)。

本次調查的主要特點

  • 本報告詳細分析了全球疫苗細胞培養基市場,以 2017 年為基準年,給出了預測期(2018-2026 年)的市場規模和複合年成長率。
  • 它還重點介紹了各個細分市場的潛在商機,並解釋了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、影響分析、波特五力分析、PEST 分析、監管環境、關鍵發展、原料分析和供應鏈分析的重要見解。
  • 本報告根據以下參數對全球疫苗細胞培養基市場的主要企業進行了分析:公司概況、財務績效、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
  • 本報告的研究結果將幫助負責人和經營團隊就未來的產品推出、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球疫苗細胞培養基市場報告的目標受眾是該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球疫苗細胞培養基市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、監理及趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • 市場機遇
  • 影響分析
  • 波特分析
  • PEST分析
  • 法規環境
  • 重大進展
  • 原料分析
  • 供應鏈分析

4. 2026-2033年全球疫苗細胞培養基市場(依培養基類型分類)

  • 牛衍生
  • 牛(FBS)
  • 新生牛血清(NBCS)
  • 牛血清(ABS)
  • 牛血清白蛋白(BSA)
  • 牛血清(BCS)
  • 源自豬
  • 不含動物性成分/無血清細胞培養

5. 2026-2033年全球疫苗細胞培養基市場(依應用領域分類)

  • 人類疫苗
  • 獸用疫苗

6. 2026-2033年全球疫苗細胞培養基市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東地區
  • 非洲
    • 南非
    • 中非
    • 北非

第7章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • HiMedia Laboratories
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • General Electric Company
    • Sartorius AG
    • Proliant, Inc.
    • Bovogen Biologicals Pty. Ltd.
    • Rocky Mountain Biologicals
    • Valley Biomedical
    • Moregate BioTech
    • Atlanta Biologicals
    • Creative-Biolabs
    • Life Technologies(India)Pvt Ltd.
    • Axil Scientific Pte Ltd.
    • Indian Immunologicals Limited
    • Serum Institute of India Pvt. Ltd.
    • Valneva SE

第8章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2608

Cell Culture Media For Vaccine Market is estimated to be valued at USD 2,217.6 Mn in 2026 and is expected to reach USD 3,727.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,217.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 3,727.4 Mn

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2017, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).

Key features of the study

  • This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter's analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
  • It profiles key players in the global cell culture media for vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market

Market Segmentation

  • By Media Type
    • Bovine Derived
    • Fetal bovine serum (FBS)
    • Newborn Calf Serum (NBCS)
    • Adult Bovine Serum (ABS)
    • Bovine Serum Albumin (BSA)
    • Bovine Calf Serum (BCS)
    • Porcine Derived
    • Animal free/Serum Free Cell Culture
  • By Application
    • Human Vaccines
    • Animal Vaccines
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • HiMedia Laboratories
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • General Electric Company
    • Sartorius AG
    • Proliant, Inc.
    • Bovogen Biologicals Pty. Ltd.
    • Rocky Mountain Biologicals
    • Valley Biomedical
    • Moregate BioTech
    • Atlanta Biologicals
    • Creative-Biolabs
    • Life Technologies (India) Pvt Ltd.
    • Axil Scientific Pte Ltd.
    • Indian Immunologicals Limited
    • Serum Institute of India Pvt. Ltd.
    • Sisco Research Laboratories Pvt. Ltd.
    • Valneva SE

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Media Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's analysis
  • PEST analysis
  • Regulatory Scenario
  • Key Developments
  • Raw material analysis
  • Supply chain analysis

4. Global Cell Culture Media for Vaccine Market, By Media Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Bovine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Fetal bovine serum (FBS)
  • Newborn Calf Serum (NBCS)
  • Adult Bovine Serum (ABS)
  • Bovine Serum Albumin (BSA)
  • Bovine Calf Serum (BCS)
  • Porcine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Animal free/Serum Free Cell Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Cell Culture Media for Vaccine Market, By Application, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Human Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Animal Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Cell Culture Media for Vaccine Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • North America
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Media Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • HiMedia Laboratories
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Merck KGaA
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • General Electric Company
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Sartorius AG
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Proliant, Inc.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Bovogen Biologicals Pty. Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Rocky Mountain Biologicals
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Valley Biomedical
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Moregate BioTech
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Atlanta Biologicals
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Creative-Biolabs
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Life Technologies (India) Pvt Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Axil Scientific Pte Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Indian Immunologicals Limited
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Serum Institute of India Pvt. Ltd.
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Valneva SE
      • Company Overview
      • Product Type Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact